Clinical Trial Update: An Evaluation of Divalproex vs. Olanzapine for Alcohol Abuse Relapse Prevention in Patients With Bipolar Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating divalproex versus olanzapine for preventing alcohol relapse in patients with bipolar disorder was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Bipolar Disorder

Drugs mentioned

• DEPAKOTE (DIVALPROEX SODIUM)
• Zyprexa (olanzapine)

Snippet

Sponsor: Mayo Clinic | Conditions: Bipolar Disorder | Phase 4 | Status: WITHDRAWN